UPDATE 2-Long-acting injection a shot in the arm for GSK's HIV business

* GSK hopes to gain market share from market leader Gilead (Updates with latest GSK and Gilead share price moves)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.